Bioprocess Automation Software Market To Reach $3.84 Billion By 2033

November 2025 | Report Format: Electronic (PDF)

Bioprocess Automation Software Market Growth & Trends

The global bioprocess automation software market size is projected to reach USD 3.84 billion by 2033, growing at a CAGR of 13.84% from 2025 to 2033, according to a new report by Grand View Research, Inc. The market is largely driven by the growing adoption of digitalization and automation across the biopharmaceutical manufacturing sector. As companies strive to improve efficiency, reproducibility, and scalability, automation software enables seamless integration of upstream and downstream processes. Platforms like MES, SCADA, and LIMS allow manufacturers to reduce manual interventions, streamline workflows, and maintain compliance with stringent regulatory standards, making automated solutions essential for modern biologics production.

Another key driver is the increasing demand for real-time monitoring and advanced data analytics in bioprocessing. Automation software equipped with sensors, process analytical technology (PAT), and AI-driven analytics enables manufacturers to track critical parameters, detect deviations early, and make data-driven adjustments. This capability improves product quality, minimizes batch failures, and accelerates development timelines, supporting both commercial and clinical manufacturing objectives.

Finally, the expansion of global biomanufacturing and the rise of contract development and manufacturing organizations (CDMOs) are fueling market growth. These organizations handle multiple client projects simultaneously, making integrated automation software critical for maintaining operational efficiency, consistency, and regulatory compliance. The trend toward continuous bioprocessing, single-use systems, and digital laboratories further reinforces the need for intelligent, scalable software solutions capable of supporting end-to-end bioprocess operations. 


key Request a free sample copy or view report summary: Bioprocess Automation Software Market Report


Bioprocess Automation Software Market Report Highlights

  • By type, the process analytical technology segment was the market leader with 31.50% share in 2024, as it enables real-time, data-driven control of critical quality attributes during biologics production.

  • By application, the downstream processing segment dominated the market in 2024 with a share of 33.34%. The increasing focus on improving efficiency and product recovery in downstream processing is a major driver of the bioprocess automation software market.

  • By end use, pharmaceutical and biotech manufacturers held the largest share of the bioprocess automation market in 2024, accounting for 36.24%. Their demand for efficient, reproducible, and compliant bioprocessing systems is vital to the establishment of large-scale operations for biologics, vaccines, and advanced therapies.

Bioprocess Automation Software Market Segmentation

Grand View Research has segmented the global bioprocess automation software market on the basis of type, application, end use, and region.

Bioprocess Automation Software Type Outlook (Revenue, USD Million, 2021 - 2033)

  • Distributed Control Systems

  • Supervisory Control and Data Acquisition

  • Manufacturing Execution Systems

  • Laboratory Information Management Systems

  • Process Analytical Technology

Bioprocess Automation Software Application Outlook (Revenue, USD Million, 2021 - 2033)

  • Upstream Processing

  • Downstream Processing

  • Quality Control

  • Manufacturing Operations

  • Data Management

Bioprocess Automation Software End Use Outlook (Revenue, USD Million, 2021 - 2033)

  • Pharmaceutical & biotech manufacturers

  • CDMOs & CMOs

  • Academic & research institutions

  • Contract testing & analytical labs

  • Others

Bioprocess Automation Software Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • China

    • India

    • Japan

    • South Korea

    • Australia

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East and Africa (MEA)

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait

List of Key Players in the Bioprocess Automation Software Market

  • Thermo Fisher Scientific, Inc.

  • Rockwell Automation

  • Agilitech

  • Amgen

  • Andrew Alliance (Waters)

  • Synthace

  • Merck KGaA

  • Eppendorf SE

  • Bioengineering AG

gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn

NEED A CUSTOM REPORT?

We offer custom report options, including stand-alone sections and country-level data. Special pricing is available for start-ups and universities.

Request Customization